https://www.selleckchem.com/pr....oducts/coelenterazin
To access the adequacy of treatment decisions in accordance with current recommendations for individualizing glycemic targets in primary and tertiary care. This multicenter cross-sectional study was conducted with a cohort of older type 2 diabetes patients from southern Brazil. Inclusion criteria were age over 65 years, having a previous diagnosis of type 2 diabetes (according to ADA criteria) and having at least two consultations registered in the medical records within one year. The primary outcome was the adequacy of treatment
Like
Comment
Share
